Santen Pharmaceutical Co Ltd (SNPHY)
Santen Pharmaceutical Market Cap: 3.729B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 3.729B |
May 16, 2024 | 3.729B |
May 15, 2024 | 3.699B |
May 14, 2024 | 3.721B |
May 13, 2024 | 3.912B |
May 10, 2024 | 3.912B |
May 09, 2024 | 3.747B |
May 08, 2024 | 3.601B |
May 07, 2024 | 3.557B |
May 06, 2024 | 3.603B |
May 03, 2024 | 3.628B |
May 02, 2024 | 3.615B |
May 01, 2024 | 3.610B |
April 30, 2024 | 3.610B |
April 29, 2024 | 3.516B |
April 26, 2024 | 3.411B |
April 25, 2024 | 3.472B |
April 24, 2024 | 3.516B |
April 23, 2024 | 3.503B |
April 22, 2024 | 3.454B |
April 19, 2024 | 3.418B |
April 18, 2024 | 3.352B |
April 17, 2024 | 3.426B |
April 16, 2024 | 3.323B |
April 15, 2024 | 3.312B |
Date | Value |
---|---|
April 12, 2024 | 3.418B |
April 11, 2024 | 3.418B |
April 10, 2024 | 3.429B |
April 09, 2024 | 3.429B |
April 08, 2024 | 3.381B |
April 05, 2024 | 3.556B |
April 04, 2024 | 3.460B |
April 03, 2024 | 3.429B |
April 02, 2024 | 3.345B |
April 01, 2024 | 3.401B |
March 28, 2024 | 3.542B |
March 27, 2024 | 3.542B |
March 26, 2024 | 3.542B |
March 25, 2024 | 3.516B |
March 22, 2024 | 3.491B |
March 21, 2024 | 3.491B |
March 20, 2024 | 3.491B |
March 19, 2024 | 3.513B |
March 18, 2024 | 3.516B |
March 15, 2024 | 3.569B |
March 14, 2024 | 3.522B |
March 13, 2024 | 3.522B |
March 12, 2024 | 3.537B |
March 11, 2024 | 3.573B |
March 08, 2024 | 3.623B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Takeda Pharmaceutical Co Ltd | 41.74B |
Nxera Pharma Co Ltd | 869.77M |
PeptiDream Inc | 1.555B |
Healios KK | 88.36M |
AnGes Inc | 72.99M |
Market Cap Related Metrics
PE Ratio | 19.95 |
PS Ratio | 1.786 |
Price to Book Value | 1.844 |
Price to Free Cash Flow | 8.698 |
Price | 10.27 |
Earnings Yield | 5.01% |
Operating PE Ratio | 13.87 |
Normalized PE Ratio | 19.95 |